NDA 021525 · Axcan Scandipharm
Photofrin
Porfimer Sodium · Injection
Priority reviewOrphanLast checked: Nov 20, 2026Latest source record: Jan 1, 2020 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
2003
Aug 1, 2003
Approved uses
1
Original approval plus efficacy supplements
Registered trials
33
7 Phase 3, 0 recruiting
FAERS reports
341
313 serious, 74 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
No structured label for this application in openFDA. Older and discontinued products often have none.
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
- Aug 1, 2003 Original approval · Type 6 - New Indication (no longer used) · priority review OrphanLabelReviewLetter
1 products under this application
- PHOTOFRIN · PORFIMER SODIUM 75MG/VIAL · Injectable, Injection · Prescription
Clinical trials
Interventional ClinicalTrials.gov studies with "Porfimer" as an intervention, any sponsor and status, largest first.
- Surgery, Radiation Therapy, and Chemotherapy With or Without Photodynamic Therapy in Treating Patients With Newly Diagnosed or Recurrent Malignant Supratentorial GliomasPivotal-lookingStatus unknown
Colorado Health FoundationAcademic, hospital or other
NCT00003788 · 270 participants (planned) · Start Apr 1998
Drug: carmustine; lomustine and 2 more · For: Brain and Central Nervous System Tumors
Sites: Englewood, Colorado; Buffalo, New York; Pittsburgh, Pennsylvania · 4 sites in all
- Biliary Stenting With or Without Photodynamic Therapy in Treating Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors That Cannot Be Removed by SurgeryPivotal-lookingCompleted
University College, LondonAcademic, hospital or other
NCT00513539 · 92 participants · Start Jul 2007 · Primary completion Dec 2009
Drug: porfimer sodium · For: Extrahepatic Bile Duct Cancer; Gallbladder Cancer
Sites: Liverpool, United Kingdom; London, United Kingdom; Nottingham, United Kingdom · 4 sites in all
- Phase II Trial of Radical Pleurectomy With or Without Intraoperative PDT for Malignant Pleural MesotheliomaActive, not recruiting
Abramson Cancer Center at Penn MedicineAcademic, hospital or other
NCT02153229 · 52 participants · Start Jun 2, 2014 · Primary completion Dec 16, 2026
Drug: Photofrin 2.0 mg/kg · For: Epitheliod Malignant Pleural Mesothelioma
Sites: Buffalo, New York; Philadelphia, Pennsylvania
University of MiamiAcademic, hospital or other
NCT00453336 · 45 participants · Start Jun 2003 · Primary completion Aug 2009
Drug: Porfimer Sodium · For: Head and Neck Cancer; Precancerous/Nonmalignant Condition
Sites: Miami, Florida
- S-1 and Photodynamic Therapy in CholangiocarcinomaPivotal-lookingCompleted
Asan Medical CenterAcademic, hospital or other
NCT00869635 · 43 participants · Start Feb 2009 · Primary completion Jul 2013
Drug: S-1 Chemotherapy · For: Cholangiocarcinoma
Sites: Seoul, South Korea
- Clinical Study of Time Optimizing of Endoscopic Photodynamic Therapy on Esophageal and/or Gastric Cardiac CancerPivotal-lookingStatus unknown
The First Affiliated Hospital of Henan University of Science and TechnologyAcademic, hospital or other
NCT02628665 · 40 participants (planned) · Start Oct 2015 · Primary completion Oct 2017
Drug: photosensitizer(photofrin) · For: Stage I Esophageal Adenocarcinoma; Stage II Esophageal Adenocarcinoma; Stage III Esophageal Adenocarcinoma and 3 more
Sites: Luoyang, China
Roswell Park Cancer InstituteAcademic, hospital or other
NCT00530088 · 30 participants · Start Oct 2001 · Primary completion Aug 2010
Drug: porfimer sodium; Photdynamic Therapy (PDT) · For: Head and Neck Cancer
Sites: Buffalo, New York
Roswell Park Cancer InstituteAcademic, hospital or other
NCT00002935 · 30 participants · Start Oct 1995 · Primary completion Aug 2006
Drug: porfimer sodium · For: Esophageal Cancer
Sites: Buffalo, New York
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
- off label use72
- cholangitis42
- oesophageal stenosis28
- dyspnoea19
- hypotension19
- sepsis15
- photosensitivity reaction14
- pneumonia14
- post procedural complication14
- swelling face13
- deep vein thrombosis12
- fatigue11
FAERS reports by year
By the date FDA received the report.
View as table
| Year | Reports |
|---|---|
| 2004 | 5 |
| 2005 | 17 |
| 2006 | 33 |
| 2007 | 31 |
| 2008 | 7 |
| 2009 | 16 |
| 2010 | 18 |
| 2011 | 5 |
| 2012 | 52 |
| 2013 | 22 |
| 2014 | 12 |
| 2015 | 30 |
| 2016 | 23 |
| 2017 | 15 |
| 2018 | 7 |
| 2019 | 10 |
| 2020 | 1 |
| 2021 | 8 |
| 2022 | 4 |
| 2023 | 5 |
| 2024 | 7 |
| 2025 | 7 |
| 2026 | 5 |
Recalls
0 FDA enforcement reports for this application.
No recalls on record for this application.
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- Treatment for Barrett's oesophagus.
Rees JR, Lao-Sirieix P, Wong A, et al. · Cochrane Database Syst Rev 2010 · Meta-Analysis, Systematic Review
- Photodynamic Therapy for Colorectal Cancer: A Systematic Review of Clinical Research.
Guidolin K, Ding L, Yan H, et al. · Surg Innov 2022 · Systematic Review
- Photodynamic therapy for recurrent nasopharyngeal cancer.
Lofgren LA, Hallgren S, Nilsson E, et al. · Arch Otolaryngol Head Neck Surg 1995 · Clinical Trial, Research Support, Non-U.S. Gov't
- Photodynamic therapy for cancers: a clinical trial of porfimer sodium in Japan.
Kato H, Horai T, Furuse K, et al. · Jpn J Cancer Res 1993 · Clinical Trial
- Photodynamic therapy for cervical intraepithelial neoplasia.
Yamaguchi S, Tsuda H, Takemori M, et al. · Oncology 2005 · Clinical Trial, Research Support, Non-U.S. Gov't
- Endoscopic application of photodynamic therapy for cholangiocarcinoma.
Rumalla A, Baron TH, Wang KK, et al. · Gastrointest Endosc 2001 · Case Reports, Clinical Trial
Sponsor: Axcan Scandipharm
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.